REVANCE THERAPEUTICS INC shareholders Q3 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,228,609$59,972,1455.67%
Essex Woodlands Management, Inc. 457,085$5,242,7654.62%
Ghost Tree Capital, LLC 350,000$4,014,5001.32%
AlphaCentric Advisors LLC 190,000$2,179,3001.24%
Sio Capital Management, LLC 342,477$3,928,2111.22%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 288,726$3,308,8001.12%
Rubric Capital Management LP 1,600,000$18,352,0000.69%
RICE HALL JAMES & ASSOCIATES, LLC 683,937$7,844,7570.50%
Rhenman & Partners Asset Management AB 361,679$4,148,4580.45%
Polar Capital Holdings Plc 4,160,311$47,718,7670.35%
Park West Asset Management LLC 319,015$3,659,1020.34%
RF&L WEALTH MANAGEMENT, LLC 28,000$321,1600.30%
EULAV Asset Management 600,000$6,882,0000.25%
Hunting Hill Global Capital, LLC 63,761$731,3390.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 870,000$9,978,9000.22%
INNOVIS ASSET MANAGEMENT LLC 38,501$441,6070.17%
DCF Advisers, LLC 26,500$303,9550.17%
Integral Health Asset Management, LLC 100,000$1,147,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 83,748$960,5900.16%
Granahan Investment Management 355,360$4,075,9790.14%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.